Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate

Citation
Zaldivar-Diez, J., Li, L., Garcia, A. M., Zhao, W.-N., Medina-Menendez, C., Haggarty, Stephen. J., Gil, C., Morales, A. V., & Martinez, A. (2019). Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate. Journal of Medicinal Chemistry, 63(5), 2638–2655. https://doi.org/10.1021/acs.jmedchem.9b01752
DOI:
DOI: 10.1021/acs.jmedchem.9b01752
Year of publication:
2020